Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
StemiRNA Therapeutics appoints Dr. Jack Hu as Chief Financial Officer 2021-12-13 07:00
Trajan to acquire LEAP PAL Parts 2021-12-09 21:00
WuXi AppTec Receives 2021 Global Customer Value Leadership Award from Frost & Sullivan 2021-12-09 08:00
Nippon Express (Nederland) Acquires GDP Compliance Certification for Company-owned Warehouse 2021-12-08 14:00
Global Cord Blood Corporation Announces Results of 2021 Annual General Meeting 2021-12-07 21:32
I-Mab to Pursue Dual Listing Plan on The Main Board of The Stock Exchange of Hong Kong Limited 2021-12-07 21:00
Samsung Biologics adds to global ISO certifications with Quality Management System 2021-12-07 13:04
Akeso Announces Launch of U.S. Investigator-Initiated Study of Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) 2021-12-07 08:20
IMPACT 2021 R&D Day: Synthetic Lethality Provides a New Platform for Targeted Cancer Therapy 2021-12-06 16:03
Kazia Announces Positive Final Data From Phase II Clinical Study Of Paxalisib In Newly Diagnosed Glioblastoma 2021-12-04 21:00
InnoCare Announces Inclusion of Orelabrutinib in China National Reimbursement Drug List 2021-12-03 10:13
Hepagene Therapeutics Initiates the RISE Study, a Phase IIa Clinical Trial of HPG1860 in Patients with NASH 2021-12-02 23:00
MingMed Biotechnology Announces U.S. FDA Approval for IND Application of HPK1 Small Molecule Inhibitor PRJ1-3024, and Completion of Phase I Clinical Trials for Dry AMD Treatment Drug QA102 2021-12-02 22:00
U.S. FDA Grants Bionomics Fast Track Designation to BNC210 for the Acute Treatment of Social Anxiety Disorder and Other Anxiety Related Disorders 2021-12-01 19:00
Great Bay Bio Completes a Near USD 10M Series A Fundraising 2021-12-01 15:00
Binhai New Area to spearhead China's medical industry development 2021-12-01 11:20
Invetech Wins International Health Award at Australian Export Awards 2021-12-01 00:00
Standigm signs MOU with Institut Pasteur Korea for AI-based drug discovery research on infectious disease 2021-11-30 21:30
ABM Therapeutics Receives IND Approval in China for BRAF Inhibitor ABM-1310 2021-11-30 13:00
CABIO receives USDA Organic certification for its Docosahexaenoic Acid Algae Oil Products 2021-11-29 21:45
1 93 94 95 96 97 222